British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update

J Psychopharmacol. 2019 Aug;33(8):923-947. doi: 10.1177/0269881119855343. Epub 2019 Jul 4.


This British Association for Psychopharmacology guideline replaces the original version published in 2010, and contains updated information and recommendations. A consensus meeting was held in London in October 2017 attended by recognised experts and advocates in the field. They were asked to provide a review of the literature and identification of the standard of evidence in their area, with an emphasis on meta-analyses, systematic reviews and randomised controlled trials where available, plus updates on current clinical practice. Each presentation was followed by discussion, aiming to reach consensus where the evidence and/or clinical experience was considered adequate, or otherwise to flag the area as a direction for future research. A draft of the proceedings was circulated to all speakers for comments, which were incorporated into the final statement.

Keywords: Sleep disorders; circadian rhythm disorders; evidence-based treatment; guidelines; insomnia; parasomnias.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Chronobiology Disorders / drug therapy*
  • Chronobiology Disorders / psychology*
  • Consensus
  • Evidence-Based Medicine / methods
  • Humans
  • London
  • Parasomnias / drug therapy*
  • Parasomnias / psychology*
  • Psychopharmacology / methods
  • Randomized Controlled Trials as Topic
  • Sleep Initiation and Maintenance Disorders / drug therapy*
  • Sleep Initiation and Maintenance Disorders / psychology*